BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 28007904)

  • 1. Cellular, biochemical and molecular changes in muscles from patients with X-linked myotubular myopathy due to MTM1 mutations.
    Bachmann C; Jungbluth H; Muntoni F; Manzur AY; Zorzato F; Treves S
    Hum Mol Genet; 2017 Jan; 26(2):320-332. PubMed ID: 28007904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Necklace" fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy.
    Bevilacqua JA; Bitoun M; Biancalana V; Oldfors A; Stoltenburg G; Claeys KG; Lacène E; Brochier G; Manéré L; Laforêt P; Eymard B; Guicheney P; Fardeau M; Romero NB
    Acta Neuropathol; 2009 Mar; 117(3):283-91. PubMed ID: 19084976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and genetic diagnosis of centronuclear myopathies in seven Chinese patients.
    Zhao Y; Zhao Z; Shen H; Bing Q; Hu J
    Neurol Sci; 2018 Dec; 39(12):2043-2051. PubMed ID: 30232666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Study of a Cohort of X-Linked Myotubular Myopathy at the Clinical, Histologic, and Genetic Levels.
    Abath Neto O; Silva MR; Martins Cde A; Oliveira Ade S; Reed UC; Biancalana V; Pesquero JB; Laporte J; Zanoteli E
    Pediatr Neurol; 2016 May; 58():107-12. PubMed ID: 26995067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the human MTM1 p.R69C mutation in murine Mtm1 results in exon 4 skipping and a less severe myotubular myopathy phenotype.
    Pierson CR; Dulin-Smith AN; Durban AN; Marshall ML; Marshall JT; Snyder AD; Naiyer N; Gladman JT; Chandler DS; Lawlor MW; Buj-Bello A; Dowling JJ; Beggs AH
    Hum Mol Genet; 2012 Feb; 21(4):811-25. PubMed ID: 22068590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of myotubularin (MTM1) leads to muscle hypotrophy through unbalanced regulation of the autophagy and ubiquitin-proteasome pathways.
    Al-Qusairi L; Prokic I; Amoasii L; Kretz C; Messaddeq N; Mandel JL; Laporte J
    FASEB J; 2013 Aug; 27(8):3384-94. PubMed ID: 23695157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centronuclear myopathy due to a de novo dominant mutation in the skeletal muscle ryanodine receptor (RYR1) gene.
    Jungbluth H; Zhou H; Sewry CA; Robb S; Treves S; Bitoun M; Guicheney P; Buj-Bello A; Bönnemann C; Muntoni F
    Neuromuscul Disord; 2007 Apr; 17(4):338-45. PubMed ID: 17376685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. X-Linked Myotubular Myopathy in a Female Patient with a Pathogenic Variant in the
    Chausova P; Murtazina A; Stepanova A; Borovicov A; Kovalskaia V; Ryadninskaya N; Chukhrova A; Ryzhkova O; Poliakov A
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice.
    Danièle N; Moal C; Julien L; Marinello M; Jamet T; Martin S; Vignaud A; Lawlor MW; Buj-Bello A
    J Neuropathol Exp Neurol; 2018 Apr; 77(4):282-295. PubMed ID: 29408998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Centronuclear (myotubular) myopathy.
    Jungbluth H; Wallgren-Pettersson C; Laporte J
    Orphanet J Rare Dis; 2008 Sep; 3():26. PubMed ID: 18817572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice.
    Tasfaout H; Buono S; Guo S; Kretz C; Messaddeq N; Booten S; Greenlee S; Monia BP; Cowling BS; Laporte J
    Nat Commun; 2017 Jun; 8():15661. PubMed ID: 28589938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphatase-dead myotubularin ameliorates X-linked centronuclear myopathy phenotypes in mice.
    Amoasii L; Bertazzi DL; Tronchère H; Hnia K; Chicanne G; Rinaldi B; Cowling BS; Ferry A; Klaholz B; Payrastre B; Laporte J; Friant S
    PLoS Genet; 2012; 8(10):e1002965. PubMed ID: 23071445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptomatic heterozygous X-Linked myotubular myopathy female patient with a large deletion at Xq28 and decrease expression of normal allele.
    Gómez-González C; Rosas-Alonso R; Rodríguez-Antolín C; García-Guede A; Ibáñez de Caceres I; Sanguino J; Pascual SI; Esteban I; Pozo AD; Mori MÁ; Torres RJ; Prior C
    Eur J Med Genet; 2021 Apr; 64(4):104170. PubMed ID: 33618039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some DNM2 mutations cause extremely severe congenital myopathy and phenocopy myotubular myopathy.
    Biancalana V; Romero NB; Thuestad IJ; Ignatius J; Kataja J; Gardberg M; Héron D; Malfatti E; Oldfors A; Laporte J
    Acta Neuropathol Commun; 2018 Sep; 6(1):93. PubMed ID: 30208955
    [No Abstract]   [Full Text] [Related]  

  • 15. Centronuclear myopathies: genotype-phenotype correlation and frequency of defined genetic forms in an Italian cohort.
    Fattori F; Maggi L; Bruno C; Cassandrini D; Codemo V; Catteruccia M; Tasca G; Berardinelli A; Magri F; Pane M; Rubegni A; Santoro L; Ruggiero L; Fiorini P; Pini A; Mongini T; Messina S; Brisca G; Colombo I; Astrea G; Fiorillo C; Bragato C; Moroni I; Pegoraro E; D'Apice MR; Alfei E; Mora M; Morandi L; Donati A; Evilä A; Vihola A; Udd B; Bernansconi P; Mercuri E; Santorelli FM; Bertini E; D'Amico A
    J Neurol; 2015 Jul; 262(7):1728-40. PubMed ID: 25957634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MTM1 mutation associated with X-linked myotubular myopathy in Labrador Retrievers.
    Beggs AH; Böhm J; Snead E; Kozlowski M; Maurer M; Minor K; Childers MK; Taylor SM; Hitte C; Mickelson JR; Guo LT; Mizisin AP; Buj-Bello A; Tiret L; Laporte J; Shelton GD
    Proc Natl Acad Sci U S A; 2010 Aug; 107(33):14697-702. PubMed ID: 20682747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-specific Mtm1 mutagenesis by an AAV-Cre vector reveals that myotubularin is essential in adult muscle.
    Joubert R; Vignaud A; Le M; Moal C; Messaddeq N; Buj-Bello A
    Hum Mol Genet; 2013 May; 22(9):1856-66. PubMed ID: 23390130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues.
    Biancalana V; Scheidecker S; Miguet M; Laquerrière A; Romero NB; Stojkovic T; Abath Neto O; Mercier S; Voermans N; Tanner L; Rogers C; Ollagnon-Roman E; Roper H; Boutte C; Ben-Shachar S; Lornage X; Vasli N; Schaefer E; Laforet P; Pouget J; Moerman A; Pasquier L; Marcorelle P; Magot A; Küsters B; Streichenberger N; Tranchant C; Dondaine N; Schneider R; Gasnier C; Calmels N; Kremer V; Nguyen K; Perrier J; Kamsteeg EJ; Carlier P; Carlier RY; Thompson J; Boland A; Deleuze JF; Fardeau M; Zanoteli E; Eymard B; Laporte J
    Acta Neuropathol; 2017 Dec; 134(6):889-904. PubMed ID: 28685322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances.
    Gómez-Oca R; Cowling BS; Laporte J
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of catalytically inactive lipid phosphatase myotubularin-related protein 12 impairs myotubularin stability and promotes centronuclear myopathy in zebrafish.
    Gupta VA; Hnia K; Smith LL; Gundry SR; McIntire JE; Shimazu J; Bass JR; Talbot EA; Amoasii L; Goldman NE; Laporte J; Beggs AH
    PLoS Genet; 2013 Jun; 9(6):e1003583. PubMed ID: 23818870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.